Association of Diffusion and Anatomic Imaging Parameters with Survival for Patients with Newly Diagnosed Glioblastoma Participating in Two Different Clinical Trials()

Documenti analoghi

• Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab
  di: Wen, Qiuting, et al.
  Pubblicazione: (2014)
• The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma
  di: Han, Seunggu J., et al.
  Pubblicazione: (2015)
• Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab
  di: Nelson, Sarah J., et al.
  Pubblicazione: (2016)
• Conditional Probability of Survival in Patients With Newly Diagnosed Glioblastoma
  di: Polley, Mei-Yin C., et al.
  Pubblicazione: (2011)
• Impact of Timing of Concurrent Chemoradiation for Newly Diagnosed Glioblastoma: A Critical Review of Current Evidence
  di: Han, Seunggu J., et al.
  Pubblicazione: (2015)